Harvard Bioscience Interest Expense 2011-2026 | HBIO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Harvard Bioscience

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-227 K	302 K	-666 K	-806 K	-469 K	5.37 M	713 K	642 K	854 K	990 K	955 K	584 K	752 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
5.37 M	-806 K	692 K

Quarterly Interest Expense Harvard Bioscience

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-365 K	-644 K	-324 K	-	-518 K	-181 K	-142 K	-	45 K	-372 K	432 K	-	-179 K	-62 K	78 K	-	-130 K	-313 K	-34 K	-	-392 K	-191 K	111 K	-	1.35 M	1.38 M	1.4 M	-	1.46 M	1.48 M	894 K	-	189 K	180 K	163 K	-	141 K	180 K	164 K	-	204 K	215 K	222 K	-	239 K	248 K	248 K	-	276 K	245 K	130 K	-	147 K	152 K	147 K	-	216 K	192 K	195 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.48 M	-644 K	197 K

Interest Expense of other stocks in the Medical instruments industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	149	-	-	$ 810 M	USA
Becton, Dickinson and Company BDX	613 M	$ 184.86	1.31 %	$ 53.2 B	USA
Baxter International BAX	290 M	$ 21.74	1.85 %	$ 11.2 B	USA
Ekso Bionics Holdings EKSO	-1 K	$ 11.29	-8.21 %	$ 228 M	USA
ICU Medical ICUI	93.3 M	$ 155.85	4.08 %	$ 3.84 B	USA
Alcon ALC	192 M	$ 82.21	-1.21 %	$ 40.4 B	Schweiz
AtriCure ATRC	683 K	$ 32.79	1.27 %	$ 1.57 B	USA
electroCore ECOR	6.3 M	$ 6.16	-0.16 %	$ 34 K	USA
LeMaitre Vascular LMAT	205 K	$ 92.55	0.75 %	$ 2.08 B	USA
AngioDynamics ANGO	4.94 M	$ 11.22	0.13 %	$ 458 M	USA
InfuSystem Holdings INFU	1.4 M	$ 7.9	-	$ 163 M	USA
The Cooper Companies COO	-16.4 M	$ 84.11	0.51 %	$ 16.7 B	USA
Haemonetics Corporation HAE	-9.75 M	$ 61.61	1.55 %	$ 3.1 B	USA
iRhythm Technologies IRTC	5.44 M	$ 150.56	-5.24 %	$ 4.82 B	USA
Isoray ISR	2 K	-	0.03 %	$ 108 M	USA
Glaukos Corporation GKOS	13.6 M	$ 119.69	2.21 %	$ 5.8 B	USA
Repro Med Systems KRMD	561 K	$ 4.72	0.64 %	$ 215 M	USA
OraSure Technologies OSUR	-380 K	$ 2.76	-2.47 %	$ 205 M	USA
Masimo Corporation MASI	300 K	$ 175.38	0.03 %	$ 9.35 B	USA
Merit Medical Systems MMSI	-711 K	$ 82.25	0.5 %	$ 4.79 B	USA
Microbot Medical MBOT	2 K	$ 2.07	-3.95 %	$ 21.1 M	Israel
Nephros NEPH	2 K	$ 4.14	6.43 %	$ 43 M	USA
Milestone Scientific MLSS	60.3 K	$ 0.26	-2.04 %	$ 20.7 M	USA
DENTSPLY SIRONA XRAY	12 M	$ 12.63	0.88 %	$ 2.57 B	USA
Envista Holdings Corporation NVST	-2.3 M	$ 29.16	1.53 %	$ 4.9 B	USA
Pro-Dex PDEX	533 K	$ 39.55	1.41 %	$ 130 M	USA
Pulse Biosciences PLSE	-52 K	$ 21.98	-12.38 %	$ 1.48 B	USA
Predictive Oncology POAI	3	-	-	$ 31.1 M	USA
Stereotaxis STXS	1.1 M	$ 2.08	-0.24 %	$ 168 M	USA
Repligen Corporation RGEN	8.12 M	$ 136.76	-0.34 %	$ 7.62 M	USA
ResMed RMD	3.2 M	$ 258.04	0.68 %	$ 37.7 B	USA
BioLife Solutions BLFS	497 K	$ 23.17	-0.26 %	$ 1.07 B	USA
STERIS plc STE	8.4 M	$ 250.32	-0.34 %	$ 24.7 B	USA
Retractable Technologies RVP	227 K	$ 0.67	-3.48 %	$ 20.1 M	USA
STAAR Surgical Company STAA	815 K	$ 17.65	-1.29 %	$ 867 M	USA
Teleflex Incorporated TFX	57 M	$ 115.88	3.65 %	$ 5.43 B	USA
Utah Medical Products UTMD	256 K	$ 67.96	2.09 %	$ 247 M	USA
West Pharmaceutical Services WST	-1 M	$ 241.54	-0.94 %	$ 17.5 B	USA